Related Experiment Video
Updated: Apr 26, 2026

Understanding the Changes in Mitochondrial Morphology through Dynamic and Three-dimensional Fluorescence Micrographs
Published on: August 15, 2025
Mechanistic target of rapamycin inhibition extends cellular lifespan in dendritic cells by preserving mitochondrial
Eyal Amiel1, Bart Everts2, Daniel Fritz3
1Department of Medical Laboratory and Radiation Sciences, College of Nursing and Health Sciences, University of Vermont, Burlington, VT 05405; Trudeau Institute, Saranac Lake, NY 12983; and.
Abstract:
TLR-mediated activation of dendritic cells (DCs) is associated with a metabolic transition in which mitochondrial oxidative phosphorylation is inhibited by endogenously synthesized NO and the cells become committed to glucose and aerobic glycolysis for survival. We show that inhibition of mechanistic target of rapamycin (mTOR) extends the lifespan of TLR-activated DCs by inhibiting the induction of NO production, thereby allowing the cells to continue to use their mitochondria to generate ATP, and allowing them the flexibility to use fatty acids or glucose as nutrients to fuel core metabolism. These data provide novel mechanistic insights into how mTOR modulates DC metabolism and cellular longevity following TLR activation and provide an explanation for previous findings that mTOR inhibition enhances the efficacy of DCs in autologous vaccination.
Insights
Inhibiting mechanistic target of rapamycin (mTOR) extends the lifespan of Toll-like receptor (TLR)-activated dendritic cells (DCs). This preserves mitochondrial function and metabolic flexibility, enhancing DC efficacy in vaccination.
Area of Science:
- Immunology
- Cellular Metabolism
- Molecular Biology
Background:
- Toll-like receptor (TLR) activation induces metabolic changes in dendritic cells (DCs).
- This involves inhibiting mitochondrial oxidative phosphorylation via nitric oxide (NO) and promoting aerobic glycolysis.
- The mechanistic target of rapamycin (mTOR) pathway plays a role in regulating these metabolic shifts.
Purpose of the Study:
- To investigate the role of mTOR in modulating DC metabolism and longevity.
- To determine how mTOR inhibition affects metabolic flexibility and ATP production in TLR-activated DCs.
- To provide mechanistic insights into enhanced DC efficacy in autologous vaccination following mTOR inhibition.
Main Methods:
- Utilized TLR-activated dendritic cell models.
- Assessed the impact of mechanistic target of rapamycin (mTOR) inhibition on NO production.
- Analyzed cellular ATP production and nutrient utilization (glucose and fatty acids).
- Evaluated the effect of mTOR inhibition on DC lifespan and function.
Main Results:
- Inhibition of mechanistic target of rapamycin (mTOR) significantly extends the lifespan of Toll-like receptor (TLR)-activated dendritic cells (DCs).
- mTOR inhibition prevents the induction of nitric oxide (NO) production, preserving mitochondrial oxidative phosphorylation.
- This allows DCs to maintain ATP generation and utilize both fatty acids and glucose for metabolism.
Conclusions:
- Mechanistic target of rapamycin (mTOR) inhibition modulates dendritic cell (DC) metabolism and cellular longevity post-Toll-like receptor (TLR) activation.
- Preserving mitochondrial function and metabolic flexibility enhances DC efficacy, explaining benefits in autologous vaccination.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Mitochondria
PI3K/mTOR/AKT Signaling Pathway
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Replicative Cell Senescence

